CME Outfitters Announces Live neuroscienceCME TV Broadcast: "Atypical Antipsychotics in Major Depressive Disorder: When Current Treatments Are Not Enough"
Offered as a simultaneous satellite broadcast, webcast, and telephone audioconference premiering Wednesday, December 3, 2008, from 12:00 p.m.-1:00 p.m. ET, the activity will incorporate the latest evidence-based augmentation treatment strategies to improve outcomes for patients with major depressive disorder.
Rockville, MD (PRWEB) October 20, 2008 -- CME Outfitters, LLC, an independent accredited provider of multidisciplinary medical education programming and related healthcare communications services, is pleased to announce an upcoming live and interactive evidence-based neuroscienceCME TV activity titled "Atypical Antipsychotics in Major Depressive Disorder: When Current Treatments Are Not Enough."
Premiering Wednesday, December 3, 2008, from 12:00 p.m.-1:00 p.m. ET, the activity will incorporate the latest evidence-based augmentation treatment strategies to improve outcomes for patients with major depressive disorder. This activity also includes a special "After the Show" segment from 1:00 p.m.-1:30 p.m. ET during which the faculty answers additional audience questions in an informal Q&A session. The recorded satellite broadcast will re-air from 3:00 p.m.-4:00 p.m. ET. This CE activity will also be available as an archived webcast, podcast, and telephone audioconference shortly after the broadcast premiere, and available as a multimedia CD-ROM in January 2009.
There is no fee to participate or receive CE credit for this activity; however, registration is required. Three forms of registration are accepted:
Online: Visit the activity details page at http://www.neuroscienceCME.com/PR341 and click the Register icon.
Phone: Call 877.CME.PROS (877.263.7767).
Fax: Visit the activity details page at http://www.neuroscienceCME.com/PR341, print and complete the activity details form, and fax to 240.243.1033.
Statement of Need:
Despite the high prevalence of MDD and the availability of effective treatments, only one-third of patients experience remission. While many patients show improvement with initial therapy, the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Trial demonstrated that it is not to the level of remission or recovery. Augmentation is particularly helpful in managing patients who have had a partial response to their initial treatment. There has been an increased use of atypical antipsychotics as augmentation agents for patients that do not achieve full remission with traditional antidepressants. For those patients requiring augmentation, is the dose of the atypical antipsychotic different, what is the risk-benefit profile for the use of these agents?
In this evidence-based neuroscienceCME TV activity, experts will explore augmentation strategies to aid clinicians in choosing an individualized treatment plan for patients with difficult to treat depression.
Moderator:
Charles B. Nemeroff, MD, PhD
Reunette W. Harris Professor
Department of Psychiatry and Behavioral Sciences
Emory University School of Medicine
Atlanta, GA
Faculty:
Linda L. Carpenter, MD
Chief, Mood Disorders Program, Butler Hospital
Associate Professor, Brown Department of Psychiatry and Human Behavior
Providence, RI
Zachary N. Stowe, MD
Director, Women's Mental Health Program
Professor in Psychiatry and Behavioral Sciences
Emory University School of Medicine
Atlanta, GA
Learning Objectives:
At the end of this CE activity, participants should be able to:
- Recognize the importance of remission and recovery as treatment goals for MDD.
- Identify the need for improved treatments and involving the patient in treatment decisions for MDD.
- Evaluate the role of atypical antipsychotics in the treatment of patients with MDD who do not achieve full remission or recovery.
Target Audience:
Physicians, physician assistants, nurse practitioners, nurses, psychologists, social workers, certified case managers, pharmacists, and other healthcare professionals with an interest in mental health.
Commercial Support:
CME Outfitters, LLC, gratefully acknowledges an educational grant from AstraZeneca Pharmaceuticals in support of this CE activity.
Credit Information:
This activity offers CE credit for:
- Physicians (ACCME/AMA PRA Category 1)
- Nurses (CNE)
- Pharmacists (ACPE)
- Psychologists (APA)
- Social Workers (NASW)
- Certified Case Managers (CCMC)
All other clinicians will either receive a CME Attendance Certificate or may choose any of the types of CE credit being offered.
Credit Expiration Date: Thursday, December 3, 2009
Post-tests, credit request forms, and activity evaluations can be completed online at www.neuroscienceCME.com (click on the Testing/Certification link under the Resources tab - requires free account activation), and participants can print their certificate or statement of credit immediately (70% pass rate required). Otherwise, participants should fully complete and return both the credit request form and activity evaluation located within the course guide for this activity. A certificate or statement of credit will be mailed within 4-6 weeks to all who successfully complete these requirements.
About CME Outfitters:
CME Outfitters develops and distributes live, recorded, print, and web-based educational activities to thousands of clinicians each year and offers expert accreditation services for non-accredited organizations. For a complete catalog of certified activities, please visit http://www.cmeoutfitters.com, http://www.neuroscienceCME.com, or call 877.CME.PROS (877.263.7767).
About neuroscienceCME:
neuroscienceCME.com is the award-winning web portal serving clinicians, educators, and researchers in the neurosciences. Launched in October 2006, neuroscienceCME.com was custom designed to fill an identified gap in online resources for professionals around the world who are practicing in areas related to psychiatry, sleep disorders, addiction and substance abuse, ADHD, and other areas related to brain function. The site's primary mission is to be the professional's central forum for accessing, debating, synthesizing, and implementing the latest findings and best practices in the neurosciences.
About neuroscienceCME TV:
Offered as a simultaneous satellite broadcast, webcast, and telephone audioconference, neuroscienceCME TV is a one-hour, live and interactive continuing education (CE) activity where leading experts discuss clinically relevant, evidence-based issues facing mental health practitioners. Each broadcast's interactivity is enhanced by offering a Q&A segment during which the faculty presenters can respond to audience comments and questions posed via webcast, email, fax, or phone. CME Outfitters has also developed a web-based instant polling feature that allows live webcast participants a chance to provide real-time input. Online CE credit is offered to participants upon completion of each activity, at neuroscienceCME.com.
To view all recent neuroscienceCME press releases, visit http://www.neuroscienceCME.com and click on "News Room" or visit http://www.prweb.com and search for "neuroscienceCME."
Clinical Compass™, a bi-weekly e-newsletter published by CME Outfitters, is a convenient way to stay informed of all neuroscienceCME news and information. To subscribe, visit http://www.neuroscienceCME.com and click on "Subscribe to Clinical Compass™."
Contact:
Jessica Primanzon
CME Outfitters, LLC
240.243.1308 direct
240.243.1033 fax
###
|
